{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T14:51:23Z","timestamp":1787842283327,"version":"build-2784847793"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T00:00:00Z","timestamp":1758499200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"DOI":"10.1007\/s00296-025-05992-3","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T08:26:39Z","timestamp":1758529599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic accuracy of anti-carbamylated protein antibodies in rheumatoid arthritis: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-5137-5998","authenticated-orcid":false,"given":"Pannathorn","family":"Nakaphan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5647-346X","authenticated-orcid":false,"given":"Patavee","family":"Pajareya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1598-6763","authenticated-orcid":false,"given":"Priabprat","family":"Jansem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4189-3621","authenticated-orcid":false,"given":"Somkiat","family":"Phutinart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-7853","authenticated-orcid":false,"given":"Nattanicha","family":"Chaisrimaneepan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8624-2759","authenticated-orcid":false,"given":"Tanattida","family":"Kassels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3315-6020","authenticated-orcid":false,"given":"Noppachai","family":"Siranart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,22]]},"reference":[{"issue":"7","key":"5992_CR1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41584-022-00786-4","volume":"18","author":"HU Scherer","year":"2022","unstructured":"Scherer HU, van der Woude D, Toes REM (2022) From risk to chronicity: evolution of autoreactive B cell and antibody responses in rheumatoid arthritis. Nat Rev Rheumatol 18(7):371\u2013383","journal-title":"Nat Rev Rheumatol"},{"issue":"9","key":"5992_CR2","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D et al (2010) 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis \\& rheumatism 62(9):2569\u20132581","journal-title":"Arthritis \\& rheumatism"},{"issue":"12","key":"5992_CR3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s00296-007-0351-4","volume":"27","author":"R Sghiri","year":"2007","unstructured":"Sghiri R et al (2007) Diagnostic performances of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Rheumatol Int 27(12):1125\u20131130","journal-title":"Rheumatol Int"},{"issue":"2","key":"5992_CR4","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1093\/rheumatology\/keaa393","volume":"60","author":"DS Courvoisier","year":"2021","unstructured":"Courvoisier DS et al (2021) The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries. Rheumatology (Oxford) 60(2):820\u2013828","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"5992_CR5","first-page":"554","volume":"41","author":"L De Stefano","year":"2023","unstructured":"De Stefano L et al (2023) Seronegative rheumatoid arthritis: one year in review 2023. Clin Exp Rheumatol 41(3):554\u2013564","journal-title":"Clin Exp Rheumatol"},{"issue":"12","key":"5992_CR6","doi-asserted-by":"publisher","first-page":"3897","DOI":"10.1007\/s00296-011-2329-5","volume":"32","author":"Y Geng","year":"2012","unstructured":"Geng Y, Zhou W, Zhang ZL (2012) A comparative study on the diversity of clinical features between the sero-negative and sero-positive rheumatoid arthritis patients. Rheumatol Int 32(12):3897\u20133901","journal-title":"Rheumatol Int"},{"issue":"4","key":"5992_CR7","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1136\/annrheumdis-2019-216694","volume":"79","author":"E Myasoedova","year":"2020","unstructured":"Myasoedova E et al (2020) Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985\u20132014. Ann Rheum Dis 79(4):440\u2013444","journal-title":"Ann Rheum Dis"},{"key":"5992_CR8","doi-asserted-by":"publisher","first-page":"9055","DOI":"10.2147\/JIR.S528487","volume":"18","author":"J Wen","year":"2025","unstructured":"Wen J et al (2025) The role and mechanism of protein Post\u2013Translational modification in rheumatoid arthritis. J Inflamm Res 18:9055\u20139078","journal-title":"J Inflamm Res"},{"issue":"12","key":"5992_CR9","doi-asserted-by":"publisher","first-page":"6882","DOI":"10.4049\/jimmunol.1000075","volume":"184","author":"P Mydel","year":"2010","unstructured":"Mydel P et al (2010) Carbamylation-dependent activation of T cells: a novel mechanism in the pathogenesis of autoimmune arthritis. J Immunol 184(12):6882\u20136890","journal-title":"J Immunol"},{"issue":"4","key":"5992_CR10","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1080\/25785826.2018.1556017","volume":"41","author":"S Nakabo","year":"2018","unstructured":"Nakabo S (2018) Clinical and etiological meaning of anti-carbamylated protein antibodies in rheumatoid arthritis. Immunol Med 41(4):147\u2013153","journal-title":"Immunol Med"},{"issue":"5","key":"5992_CR11","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/clpt.1980.87","volume":"27","author":"S Erill","year":"1980","unstructured":"Erill S, Calvo R, Carlos R (1980) Plasma protein carbamylation and decreased acidic drug protein binding in uremia. Clin Pharmacol Ther 27(5):612\u2013618","journal-title":"Clin Pharmacol Ther"},{"issue":"14","key":"5992_CR12","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1056\/NEJM198104023041406","volume":"304","author":"R Fl\u00fcckiger","year":"1981","unstructured":"Fl\u00fcckiger R et al (1981) Hemoglobin carbamylation in uremia. N Engl J Med 304(14):823\u2013827","journal-title":"N Engl J Med"},{"issue":"10","key":"5992_CR13","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/nm1637","volume":"13","author":"Z Wang","year":"2007","unstructured":"Wang Z et al (2007) Protein carbamylation links inflammation, smoking, uremia and atherogenesis. Nat Med 13(10):1176\u20131184","journal-title":"Nat Med"},{"issue":"42","key":"5992_CR14","doi-asserted-by":"publisher","first-page":"17372","DOI":"10.1073\/pnas.1114465108","volume":"108","author":"J Shi","year":"2011","unstructured":"Shi J et al (2011) Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage. Proc Natl Acad Sci U S A 108(42):17372\u201317377","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5992_CR15","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.autrev.2017.11.017","volume":"17","author":"MK Verheul","year":"2018","unstructured":"Verheul MK et al (2018) Pitfalls in the detection of citrullination and carbamylation. Autoimmun Rev 17(2):136\u2013141","journal-title":"Autoimmun Rev"},{"issue":"1","key":"5992_CR16","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s13075-017-1455-1","volume":"19","author":"MK Verheul","year":"2017","unstructured":"Verheul MK et al (2017) Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis. Arthritis Res Ther 19(1):246","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"5992_CR17","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1136\/annrheumdis-2015-207751","volume":"75","author":"B Bergum","year":"2016","unstructured":"Bergum B et al (2016) Antibodies against carbamylated proteins are present in primary sj\u00f6gren\u2019s syndrome and are associated with disease severity. Ann Rheum Dis 75(8):1494\u20131500","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"5992_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s13075-018-1622-z","volume":"20","author":"F Ceccarelli","year":"2018","unstructured":"Ceccarelli F et al (2018) Anti-carbamylated protein antibodies as a new biomarker of erosive joint damage in systemic lupus erythematosus. Arthritis Res Ther 20(1):126","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"5992_CR19","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1177\/0961203319897127","volume":"29","author":"Y Li","year":"2020","unstructured":"Li Y et al (2020) Antibodies against carbamylated vimentin exist in systemic lupus erythematosus and correlate with disease activity. Lupus 29(3):239\u2013247","journal-title":"Lupus"},{"issue":"6","key":"5992_CR20","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1016\/j.joca.2021.03.008","volume":"29","author":"X Xie","year":"2021","unstructured":"Xie X et al (2021) Auto-antibodies to post-translationally modified proteins in osteoarthritis. Osteoarthritis Cartilage 29(6):924\u2013933","journal-title":"Osteoarthritis Cartilage"},{"issue":"1","key":"5992_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12891-021-04985-0","volume":"23","author":"S Oka","year":"2022","unstructured":"Oka S et al (2022) Serum rheumatoid factor iga, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis. BMC Musculoskelet Disord 23(1):46","journal-title":"BMC Musculoskelet Disord"},{"issue":"1","key":"5992_CR22","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1038\/s41598-021-89502-y","volume":"11","author":"C Regueiro","year":"2021","unstructured":"Regueiro C et al (2021) Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies. Sci Rep 11(1):9945","journal-title":"Sci Rep"},{"key":"5992_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413290","author":"C Garc\u00eda-Moreno","year":"2021","unstructured":"Garc\u00eda-Moreno C et al (2021) Peptides bearing multiple post-translational modifications as antigenic targets for severe rheumatoid arthritis patients. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms222413290","journal-title":"Int J Mol Sci"},{"issue":"4","key":"5992_CR24","doi-asserted-by":"publisher","first-page":"e284","DOI":"10.1016\/S2665-9913(20)30381-7","volume":"3","author":"JS Nijjar","year":"2021","unstructured":"Nijjar JS et al (2021) The impact of autoantibodies against citrullinated, carbamylated, and acetylated peptides on radiographic progression in patients with new-onset rheumatoid arthritis: an observational cohort study. Lancet Rheumatol 3(4):e284\u2013e293","journal-title":"Lancet Rheumatol"},{"issue":"5","key":"5992_CR25","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/annrheumdis-2019-216709","volume":"79","author":"R Castellanos-Moreira","year":"2020","unstructured":"Castellanos-Moreira R et al (2020) Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease. Ann Rheum Dis 79(5):587\u2013594","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5992_CR26","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1093\/rheumatology\/keaa549","volume":"60","author":"NA Elsawy","year":"2021","unstructured":"Elsawy NA et al (2021) Anti-carbamylated protein antibodies in premenopausal rheumatoid arthritis women: relation to disease activity and bone loss. Rheumatology (Oxford) 60(3):1419\u20131428","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"5992_CR27","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/art.41623","volume":"73","author":"J Amkreutz","year":"2021","unstructured":"Amkreutz J et al (2021) Association between bone mineral density and autoantibodies in patients with rheumatoid arthritis. Arthritis Rheumatol 73(6):921\u2013930","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"5992_CR28","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1186\/s12891-021-04248-y","volume":"22","author":"A Juli\u00e0","year":"2021","unstructured":"Juli\u00e0 A et al (2021) Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy. BMC Musculoskelet Disord 22(1):372","journal-title":"BMC Musculoskelet Disord"},{"issue":"11","key":"5992_CR29","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY et al (2011) Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int 31(11):1409\u20131417","journal-title":"Rheumatol Int"},{"issue":"3","key":"5992_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R DerSimonian","year":"1986","unstructured":"DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177\u2013188","journal-title":"Control Clin Trials"},{"issue":"9","key":"5992_CR31","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.jclinepi.2005.01.016","volume":"58","author":"JJ Deeks","year":"2005","unstructured":"Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58(9):882\u2013893","journal-title":"J Clin Epidemiol"},{"key":"5992_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14222485","author":"I Haro","year":"2024","unstructured":"Haro I et al (2024) Anti-Modified peptide antibodies (AMPAs) in rheumatoid arthritis: study of the diagnostic value of citrullinated, homocitrullinated, and acetylated fibrin\/filaggrin chimeric peptides. Diagnostics. https:\/\/doi.org\/10.3390\/diagnostics14222485","journal-title":"Diagnostics"},{"issue":"3","key":"5992_CR33","doi-asserted-by":"publisher","first-page":"302","DOI":"10.3899\/jrheum.170446","volume":"45","author":"P Lac","year":"2018","unstructured":"Lac P et al (2018) Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis. J Rheumatol 45(3):302\u2013309","journal-title":"J Rheumatol"},{"key":"5992_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17091510","author":"HC Yu","year":"2016","unstructured":"Yu HC et al (2016) Increased serum levels of anti-carbamylated 78-kDa glucose-regulated protein antibody in patients with rheumatoid arthritis. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms17091510","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5992_CR35","first-page":"1332","volume":"43","author":"G Zhang","year":"2025","unstructured":"Zhang G et al (2025) Cross-reactivity of anti-modified protein antibodies in rheumatoid arthritis. Clin Exp Rheumatol 43(7):1332\u20131344","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"5992_CR36","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00296-015-3271-8","volume":"35","author":"W Katchamart","year":"2015","unstructured":"Katchamart W et al (2015) Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatol Int 35(10):1693\u20131699","journal-title":"Rheumatol Int"},{"issue":"4","key":"5992_CR37","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s00296-019-04492-5","volume":"40","author":"J Grosse","year":"2020","unstructured":"Grosse J et al (2020) ACPA-positive versus ACPA-negative rheumatoid arthritis: two distinct erosive disease entities on radiography and ultrasonography. Rheumatol Int 40(4):615\u2013624","journal-title":"Rheumatol Int"},{"issue":"12","key":"5992_CR38","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00296-023-05445-9","volume":"43","author":"LM Amezcua-Guerra","year":"2023","unstructured":"Amezcua-Guerra LM et al (2023) Influence of anti-carbamylated protein antibodies on disease activity and joint erosions in seronegative and seropositive rheumatoid arthritis. Rheumatol Int 43(12):2245\u20132250","journal-title":"Rheumatol Int"},{"issue":"7","key":"5992_CR39","doi-asserted-by":"publisher","first-page":"e0159000","DOI":"10.1371\/journal.pone.0159000","volume":"11","author":"L Li","year":"2016","unstructured":"Li L et al (2016) Meta-analysis: diagnostic accuracy of anti-carbamylated protein antibody for rheumatoid arthritis. PLoS ONE 11(7):e0159000","journal-title":"PLoS ONE"},{"issue":"1","key":"5992_CR40","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.70058","volume":"28","author":"Q Zhou","year":"2025","unstructured":"Zhou Q, Li N, Hu J (2025) Diagnostic value of combined test of anti-cyclic citrullinated peptide antibody, AKA antibody, carp antibody, and rheumatoid factor for rheumatoid arthritis. Int J Rheum Dis 28(1):e70058","journal-title":"Int J Rheum Dis"},{"issue":"1","key":"5992_CR41","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13075-024-03470-y","volume":"27","author":"A Floris","year":"2025","unstructured":"Floris A et al (2025) The role of anti-PAD4, anti-CarP, and anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis. Arthritis Res Ther 27(1):9","journal-title":"Arthritis Res Ther"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05992-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-025-05992-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-025-05992-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:04:21Z","timestamp":1761847461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-025-05992-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,22]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["5992"],"URL":"https:\/\/doi.org\/10.1007\/s00296-025-05992-3","relation":{},"ISSN":["1437-160X"],"issn-type":[{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,22]]},"assertion":[{"value":"21 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article is a systematic review and meta-analysis of previously published studies. No new data involving human participants or animals were collected.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"232"}}